Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2025 / Aug / Decoding the Vaginal Microbiome
Microbiology & Immunology Biochemistry and molecular biology Precision medicine Research and Innovations

Decoding the Vaginal Microbiome

Review outlines possible diagnostic applications in gynecological cancers, fertility, pregnancy, and postmenopausal care

08/26/2025 News 2 min read

Share

A review in Frontiers in Cellular and Infection Microbiologyexplores how analyzing the vaginal microbiome could improve diagnostic testing for a range of women’s health conditions.

Credit: Adobe Stock

The vaginal microbiome is typically dominated by Lactobacillus species, which help maintain an acidic pH and protect against pathogens. Disruption to this balance – known as dysbiosis – has been linked to bacterial vaginosis (BV), sexually transmitted infections (STIs), certain cancers, and complications in pregnancy and fertility.

Current tests for BV, such as Amsel’s criteria and Nugent scoring, can be subjective and may miss important microbial changes. In STIs, conventional methods focus on specific pathogens, whereas microbiome profiling could detect broader shifts that signal risk before symptoms appear.

For cervical cancer, persistent infection with high-risk human papillomavirus (HPV) is a major cause. Research suggests that microbiome composition may influence susceptibility, offering a potential addition to existing screening methods.

The review points to possible diagnostic applications for:

Gynecological cancers: Certain microbial profiles may be linked to cervical, endometrial, and ovarian cancers.

Fertility and pregnancy: Microbiome changes could help predict reduced fertility or higher risk of preterm birth.

Postmenopausal conditions: Species linked to genitourinary syndrome of menopause could serve as markers for diagnosis and monitoring.

The authors highlight that variability in study design and laboratory methods has hindered the comparability of microbiome research. They recommend developing vaginal microbiome-specific reference reagents, standardizing protocols, and ensuring robust clinical trial design to support regulatory compliance and integration into clinical workflows.

The review concludes that incorporating microbiome profiling into diagnostic strategies could enhance precision in women’s health testing. Such tools, if standardized and clinically validated, could complement existing methods, support earlier detection, and inform targeted treatment approaches.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Turning Tides
Biochemistry and molecular biology
Turning Tides

January 9, 2024

3 min read

A new study shows evidence for sustained human-to-human transmission of mpox since 2016

Molecular Spectacular
Biochemistry and molecular biology
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

qPCR Infectious Disease Detective
Biochemistry and molecular biology
qPCR: Infectious Disease Detective

January 4, 2024

3 min read

How quantitative polymerase chain reaction really hits the mark in epidemic control and ID detection

Case of the Month
Biochemistry and molecular biology
Case of the Month

January 11, 2022

1 min read

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.